Error: Could not add to watchlist. X

Akebia Therapeutics Inc

+ Watchlist
AKBA:US
NASDAQ GM
9.40
USD
0.04
0.43%
As of 20:10:00 ET on 07/31/2015.
Open
9.37
Day Range
8.98 - 9.41
Volume
171,734
Previous Close
9.36
52Wk Range
7.27 - 26.77
1 Yr Return
-57.54%
Open
9.37
Day Range
8.98 - 9.41
Volume
171,734
Previous Close
9.36
52Wk Range
7.27 - 26.77
1 Yr Return
-57.54%
YTD Return
-19.24%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-7.88
Market Cap (m USD)
271.070
Shares Outstanding (m)
28.837
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.
ADDRESS
245 First Street
Suite 1100
Cambridge, MA 02142
United States
PHONE
1-617-871-2098
  • John P Butler
    President/CEO
  • Jason A Amello
    Senior VP/CFO/Treasurer
  • Bradley J Maroni
    Senior VP/Chief Medical Officer
  • Nicole R Hadas "Nikki"
    Senior VP/Secy/Gen Cnsl
Show More